Fetzima
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0456-2200 -
Package NDC
0456-2200-07 -
Application number
NDA204168 -
SPL ID
b4f9c587-d1eb-462b-bad2-ed0ce6d76c57 -
SPL set ID
f371258d-91b3-4b6a-ac99-434a1964c3af -
UNII
371U2ZK31U -
RxCUI
1433217 -
RxCUI
1433223 -
RxCUI
1433227 -
RxCUI
1433229 -
RxCUI
1433233 -
RxCUI
1433235 -
RxCUI
1433239 -
RxCUI
1433241 -
RxCUI
1433249 -
RxCUI
1433250 -
RxCUI
2636817 -
RxCUI
2636818
What the source publishes
- Labeler
- Allergan, Inc.
- Active ingredients
- LEVOMILNACIPRAN HYDROCHLORIDE
- Form
- KIT
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Fetzima",
"splId": "b4f9c587-d1eb-462b-bad2-ed0ce6d76c57",
"labels": [
{
"setId": "f371258d-91b3-4b6a-ac99-434a1964c3af",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f371258d-91b3-4b6a-ac99-434a1964c3af",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f371258d-91b3-4b6a-ac99-434a1964c3af"
}
],
"routes": [
"ORAL"
],
"labeler": "Allergan, Inc.",
"finished": true,
"packaging": [
{
"sample": true,
"description": "1 BLISTER PACK in 1 CARTON (0456-2200-07) / 1 KIT in 1 BLISTER PACK (0456-2200-65) * 2 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (0456-2220-00) * 5 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (0456-2240-00)",
"package_ndc": "0456-2200-07",
"identifierStatus": "well-formed",
"marketing_start_date": "20230324"
}
],
"productId": "0456-2200_b4f9c587-d1eb-462b-bad2-ed0ce6d76c57",
"useDomain": "unknown",
"dosageForm": "KIT",
"productNdc": "0456-2200",
"deaSchedule": null,
"genericName": "LEVOMILNACIPRAN HYDROCHLORIDE",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [],
"applicationNumber": "NDA204168",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20230324",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0304562240301"
],
"unii": [
"371U2ZK31U"
],
"rxcui": [
"1433217",
"1433223",
"1433227",
"1433229",
"1433233",
"1433235",
"1433239",
"1433241",
"1433249",
"1433250",
"2636817",
"2636818"
],
"spl_set_id": [
"f371258d-91b3-4b6a-ac99-434a1964c3af"
],
"manufacturer_name": [
"Allergan, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0456-2200_b4f9c587-d1eb-462b-bad2-ed0ce6d76c57"